A reduced-carbohydrate diet improves outcomes in patients with metabolic syndrome: A translational study

Topics in Clinical Nutrition

Volumn 22, Issue 1, 2007, Pages 82-91

  Miller, Carla K ^a   Ulbrecht, Jan S ^a,b   Lyons, Joanna ^a   Parker Klees, Lynn ^b   Gutschall, Melissa Davis ^a   Smiciklas Wright, Helen ^a   Mitchell, Diane C ^a   Covasa, Mihai ^a   Hayes, Matthew ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b Centre Medical Surgical Associates PC   (United States)

Author keywords

Metabolic syndrome; Nutrition assessment; Obesity; Weight reduction

Indexed keywords

GLUCOSE; LIPID;

ADULT; ANALYTIC METHOD; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CARBOHYDRATE DIET; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; MALE; METABOLIC SYNDROME X; NUTRITIONAL ASSESSMENT; NUTRITIONAL COUNSELING; OUTCOME ASSESSMENT; OUTPATIENT; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

EID: 33846946873     PISSN: 08835691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008486-200701000-00009     Document Type: Article

References (32)

1. Katzmarzyk PT, Church TS, Janssen I, Ross R, Blair SN. Metabolic syndrome, obesity and mortality: impact of cardiorespiratory fitness. Diab Care. 2005;28:391-397.
2. Meigs JB, Williams K, Sullivan LM, et al. Using metabolic syndrome traits for efficient detection of impaired glucose tolerance. Diab Care. 2004;27:1417-1426.
3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report on the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
4. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diab Care. 2004;27:2444-2449.
5. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diab Care. 1991;14:173-194.
6. Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev. 1995;75:473-486.
7. Foster GD, Wyatt HR, Hill JO, et al. A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med. 2003;348:2082-2090.
8. Aude YW, Agatston AS, Lopez-Jimenez F, et al. The national cholesterol education program diet vs. a diet lower in carbohydrates and higher in protein and monounsaturated fat. Arch Intern Med. 2004;164:2141-2146.
9. Samaha FF, Iqbal N, Seshadri P, et al. A lowcarbohydrate as compared with a low-fat diet in severe obesity. N Engl J Med. 2003;348:2074-2081.
10. Volek JS, Sharman MJ, Love DM, et al. Body composition and hormonal responses to a carbohydraterestricted diet. Metabolism. 2002;51:864-870.
11. Agatston A. The South Beach Diet. New York: Random House; 2003.
12. Foster-Powell K, Holt SHA, Brand-Miller JC. International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr. 2002;76:55-56.
13. Blair SN, Haskell WL, Ho P, et al. Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments. Am J Epidemiol. 1985;122:794-804.
14. Sallis JF, Haskell WL, Wood PD, et al. Physical activity assessment methodology in the five-city project. Am J Epidemiol. 1985;121:91-106.
15. Katz A, Nambi SS, Mather K, et al. Quantitative Insulin Sensitivity Check Index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endoc Metab. 2000;85:2402-2410.
16. LaRosa JC, Fry AG, Muesing R, Rosing DR. Effects of high-protein, low-carbohydrate dieting on plasma lipoproteins and body weight. J Am Diet Assoc. 1980;77:264-270.
17. Dansinger ML, Gleason JA, Griffith JL, Selker HP, Schaefer EJ. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA. 2005;293:43-53.
18. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or Metformin. New Engl J Med. 2002;346:393-403.
19. The Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, phase I. JAMA. 1992;267:1213-1220.
20. The Trials of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure: the Trials of Hypertension Prevention, phase II. Arch Intern Med. 1997;157:657-667.
21. Cook NR, Cohen J, Hebert P, Taylor JO, Hennekens CH. Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med. 1995;155:701-709.
22. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a metaanalysis of population-based prospective studies. J Cardiovasc Risk. 1996;3:213-219.
23. Parks EJ. Effect of dietary carbohydrate on triglyceride metabolism in humans. J Nutr. 2001;131:2772S-2774S.
24. Parks EJ, Hellerstein MK. Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms. Am J Clin Nutr. 2000;71:412-433.
25. Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins: a meta-analysis of 27 trials. Arterioscler Thromb. 1992;12:911-919.
26. Yang EJ, Chung HK, Kim WY, Kerver JM, Song WO. Carbohydrate intake is associated with diet quality and risk factors for cardiovascular disease in U.S. adults: NHANES III. J Am Coll Nutr. 2002;22:71-79.
27. Ginsberg NH. Is hypertriglyceridemia a risk factor for atherosclerotic cardiovascular disease? A simple question with a complicated answer. Ann Intern Med. 1997;126:912-914.
28. Miller M, Seidler A, Moalemi A, Pearson TA. Normal triglyceride levels and coronary artery disease events: the Baltimore coronary observational long-term study. J Am Coll Cardiol. 1998;31:1252-1257.
29. Tenkanen L, Manttari M, Kovanen PT, Virkkunen H, Manninen V. Gemfibrozil in the treatment of dyslipidemia: an 18-year mortality follow-up of the Helsinki Heart Study. Arch Intern Med. 2006;166:743-748.
30. Dattilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr. 1992;56:320-328.
31. Eberly LE, Prineas R, Cohen JD, et al, for the Multiple Risk Factor Intervention Trial Research Group. Metabolic syndrome: risk factor distribution and 18-year mortality in the multiple risk factor intervention trial. Diab Care. 2006;29:123-130.
32. Bravata DM, Sanders L, Huang J, et al. Efficacy and safety of low-carbohydrate diets: a systematic review. JAMA. 2003;289:1837-1850.